{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:38:06Z","timestamp":1772246286354,"version":"3.50.1"},"reference-count":75,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2015.00273","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T09:47:56Z","timestamp":1433238476000},"source":"Crossref","is-referenced-by-count":20,"title":["Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model"],"prefix":"10.3389","volume":"6","author":[{"given":"Claudia","family":"Carvalho-Queiroz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Nyakundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Ogongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitler","family":"Rikoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat K.","family":"Egilmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idle O.","family":"Farah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip T.","family":"LoVerde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"issue":"2","key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0001-706X(02)00045-1","article-title":"The global epidemiological situation of schistosomiasis and new approaches to control and research","volume":"82","author":"Engels","year":"2002","journal-title":"Acta Trop"},{"issue":"9674","key":"B2","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"B3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N Engl J Med"},{"issue":"9708","key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0140-6736(09)62174-7","article-title":"David Molyneux: raising the profile of neglected tropical diseases","volume":"375","author":"Kirby","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"B5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/01.qco.0000247591.13671.6a","article-title":"Schistosomiasis: challenges for control, treatment and drug resistance","volume":"19","author":"Fenwick","year":"2006","journal-title":"Curr Opin Infect Dis"},{"issue":"13","key":"B6","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1017\/S0031182009990400","article-title":"The schistosomiasis control initiative (SCI): rationale, development and implementation from 2002-2008","volume":"136","author":"Fenwick","year":"2009","journal-title":"Parasitology"},{"issue":"2","key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2471\/BLT.06.030353","article-title":"Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren","volume":"85","author":"Kabatereine","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"3","key":"B8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.trstmh.2005.03.015","article-title":"Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda","volume":"100","author":"Kabatereine","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"B9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol"},{"issue":"4","key":"B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pt.2009.01.004","article-title":"Diagnostic dilemmas in helminthology: what tools to use and when?","volume":"25","author":"Bergquist","year":"2009","journal-title":"Trends Parasitol"},{"issue":"6","key":"B11","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1371\/journal.pntd.0000244","article-title":"Trick or treat: the role of vaccines in integrated schistosomiasis control","volume":"2","author":"Bergquist","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"9399","key":"B12","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(03)14968-9","article-title":"Sustainable schistosomiasis control \u00e2\u20ac\u201c the way forward","volume":"362","author":"Utzinger","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"B13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/expr.1997.4229","article-title":"The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel","volume":"87","author":"Bennett","year":"1997","journal-title":"Exp Parasitol"},{"issue":"1","key":"B14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4269\/ajtmh.1995.53.61","article-title":"Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni","volume":"53","author":"Fallon","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"B15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4269\/ajtmh.2006.75.278","article-title":"Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy","volume":"75","author":"Koukounari","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"B16","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1128\/IAI.00757-06","article-title":"Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation","volume":"74","author":"Leenstra","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/infdis\/174.1.163","article-title":"Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity","volume":"174","author":"Olveda","year":"1996","journal-title":"J Infect Dis"},{"issue":"7","key":"B18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1742395307084407","article-title":"The unacknowledged impact of chronic schistosomiasis","volume":"4","author":"King","year":"2008","journal-title":"Chronic Illn"},{"issue":"1","key":"B20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/S0074-02762006000900004","article-title":"Schistosome vaccines: a critical appraisal","volume":"101","author":"Wilson","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"24","key":"B22","first-page":"3595","article-title":"The redox biology of schistosome parasites and applications for drug development","volume":"18","author":"Huang","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"7","key":"B23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0169-4758(98)01261-7","article-title":"Do antioxidants play a role in schistosome host-parasite interactions?","volume":"14","author":"Loverde","year":"1998","journal-title":"Parasitol Today"},{"issue":"10","key":"B24","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1128\/IAI.64.10.4299-4306.1996","article-title":"Expression and characterization of glutathione peroxidase activity in the human blood fluke Schistosoma mansoni","volume":"64","author":"Mei","year":"1996","journal-title":"Infect Immun"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/expr.1997.4150","article-title":"Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes","volume":"86","author":"Mei","year":"1997","journal-title":"Exp Parasitol"},{"issue":"3","key":"B26","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.4049\/jimmunol.166.3.1903","article-title":"IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis","volume":"166","author":"La Flamme","year":"2001","journal-title":"J Immunol"},{"issue":"9","key":"B27","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/IAI.60.9.3641-3651.1992","article-title":"Identification and purification of a second form of Cu\/Zn superoxide dismutase from Schistosoma mansoni","volume":"60","author":"Hong","year":"1992","journal-title":"Infect Immun"},{"issue":"6449","key":"B28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/365797a0","article-title":"Immunological modulation and evasion by helminth parasites in human populations","volume":"365","author":"Maizels","year":"1993","journal-title":"Nature"},{"issue":"1","key":"B29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0264-410X(03)00535-8","article-title":"Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu\/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes","volume":"22","author":"Shalaby","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"B30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0169-4758(95)80157-X","article-title":"Controlling schistosomiasis by vaccination: a realistic option?","volume":"11","author":"Bergquist","year":"1995","journal-title":"Parasitol Today"},{"issue":"10","key":"B31","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1128\/IAI.72.10.6112-6124.2004","article-title":"Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage","volume":"72","author":"Cook","year":"2004","journal-title":"Infect Immun"},{"issue":"5","key":"B32","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1128\/IAI.72.5.2635-2647.2004","article-title":"Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes","volume":"72","author":"Carvalho-Queiroz","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"B33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/hum.1996.7.10-1205","article-title":"An improved plasmid DNA expression vector for direct injection into skeletal muscle","volume":"7","author":"Hartikka","year":"1996","journal-title":"Hum Gene Ther"},{"issue":"9","key":"B34","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.151.9.4782","article-title":"Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent","volume":"151","author":"Soisson","year":"1993","journal-title":"J Immunol"},{"issue":"7","key":"B35","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1128\/IAI.01657-05","article-title":"Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine","volume":"74","author":"Kariuki","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"B36","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni","volume":"14","author":"Katz","year":"1972","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"4","key":"B37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2307\/3283784","article-title":"Schistosoma mansoni induces in the Kenyan baboon a novel intestinal pathology that is manifestly modulated by an irradiated cercarial vaccine","volume":"82","author":"Farah","year":"1996","journal-title":"J Parasitol"},{"issue":"12","key":"B38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0169-4758(99)01569-0","article-title":"The baboon as a non-human primate model of human schistosome infection","volume":"15","author":"Nyindo","year":"1999","journal-title":"Parasitol Today"},{"issue":"Suppl 4","key":"B39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1590\/S0074-02761992000800041","article-title":"Further development of the baboon as a model for acute schistosomiasis","volume":"87","author":"Damian","year":"1992","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"B40","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00436-008-0887-6","article-title":"Experimental vaccines in animal models for schistosomiasis","volume":"102","author":"Siddiqui","year":"2008","journal-title":"Parasitol Res"},{"issue":"Suppl 1","key":"B41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/S0074-02762006000900061","article-title":"Schistosome vaccine testing: lessons from the baboon model","volume":"101","author":"Coulson","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"B42","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1128\/IAI.72.9.5526-5529.2004","article-title":"Parameters of the attenuated schistosome vaccine evaluated in the olive baboon","volume":"72","author":"Kariuki","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"B43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"O\u00e2\u20ac\u2122Hagan","year":"2001","journal-title":"Biomol Eng"},{"issue":"2","key":"B44","first-page":"239","article-title":"Biodegradable microparticles as controlled release antigen delivery systems","volume":"73","author":"O\u00e2\u20ac\u2122Hagan","year":"1991","journal-title":"Immunology"},{"issue":"1","key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v12.i1.10","article-title":"Biodegradable microspheres in drug delivery","volume":"12","author":"Okada","year":"1995","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"6623","key":"B46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/386410a0","article-title":"Biologically erodable microspheres as potential oral drug delivery systems","volume":"386","author":"Mathiowitz","year":"1997","journal-title":"Nature"},{"issue":"1","key":"B47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s002620050455","article-title":"Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft\/SCID mouse model","volume":"46","author":"Egilmez","year":"1998","journal-title":"Cancer Immunol Immunother"},{"issue":"14","key":"B48","first-page":"3832","article-title":"In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity","volume":"60","author":"Egilmez","year":"2000","journal-title":"Cancer Res"},{"issue":"13\u00e2\u20ac\u201c14","key":"B49","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0264-410X(01)00508-4","article-title":"Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres","volume":"20","author":"Rosas","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/jps.10042","article-title":"Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres","volume":"91","author":"Shi","year":"2002","journal-title":"J Pharm Sci"},{"issue":"2\u00e2\u20ac\u201c3","key":"B51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0169-409X(98)00045-3","article-title":"Microparticles and polymers for the mucosal delivery of vaccines","volume":"34","author":"O\u00e2\u20ac\u2122Hagan","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"9\u00e2\u20ac\u201c10","key":"B52","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0264-410X(02)00531-5","article-title":"Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro","volume":"21","author":"Sun","year":"2003","journal-title":"Vaccine"},{"issue":"11","key":"B53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-3024.1997.d01-163.x","article-title":"Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase","volume":"19","author":"Dupre","year":"1997","journal-title":"Parasite Immunol"},{"issue":"5 Suppl 1","key":"B54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1590\/S0074-02762004000900007","article-title":"Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni","volume":"99","author":"LoVerde","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"B55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/oxfordjournals.bmb.a011693","article-title":"Immunological aspects of human schistosomiasis","volume":"54","author":"Butterworth","year":"1998","journal-title":"Br Med Bull"},{"issue":"7","key":"B56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"Pearce","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"B57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","article-title":"Immunology of human schistosomiasis","volume":"36","author":"Colley","year":"2014","journal-title":"Parasite Immunol"},{"issue":"9","key":"B58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0169-4758(00)01740-3","article-title":"Natural versus drug-induced resistance in Schistosoma mansoni infection","volume":"16","author":"Correa-Oliveira","year":"2000","journal-title":"Parasitol Today"},{"issue":"11","key":"B59","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0169-4758(00)01788-9","article-title":"Defining a schistosomiasis vaccination strategy \u00e2\u20ac\u201c is it really Th1 versus Th2?","volume":"16","author":"Wynn","year":"2000","journal-title":"Parasitol Today"},{"issue":"6","key":"B60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri2992","article-title":"Diversity and dialogue in immunity to helminths","volume":"11","author":"Allen","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"B61","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/infdis\/jiu031","article-title":"Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons","volume":"209","author":"Karmakar","year":"2014","journal-title":"J Infect Dis"},{"issue":"8","key":"B62","doi-asserted-by":"publisher","first-page":"e1002171","DOI":"10.1371\/journal.ppat.1002171","article-title":"IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni","volume":"7","author":"Wilson","year":"2011","journal-title":"PLoS Pathog"},{"issue":"1","key":"B63","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/infdis\/jis524","article-title":"Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis","volume":"208","author":"Bourke","year":"2013","journal-title":"J Infect Dis"},{"issue":"12","key":"B64","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1128\/IAI.67.12.6565-6571.1999","article-title":"Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment","volume":"67","author":"Mola","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"B65","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pntd.0000442","article-title":"Do antenatal parasite infections devalue childhood vaccination?","volume":"3","author":"Labeaud","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"B66","doi-asserted-by":"publisher","first-page":"e0003466","DOI":"10.1371\/journal.pntd.0003466","article-title":"Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya","volume":"9","author":"Malhotra","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"B67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/08820139209069381","article-title":"Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control","volume":"21","author":"Butterworth","year":"1992","journal-title":"Immunol Invest"},{"issue":"3","key":"B68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pt.2013.12.009","article-title":"Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology","volume":"30","author":"Chuah","year":"2014","journal-title":"Trends Parasitol"},{"issue":"2\u00e2\u20ac\u201c3","key":"B69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.actatropica.2008.04.016","article-title":"The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection","volume":"108","author":"Souza","year":"2008","journal-title":"Acta Trop"},{"issue":"1","key":"B70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4269\/ajtmh.13-0270","article-title":"Chemokine profile in the sera and urine of patients with schistosomal glomerulopathy","volume":"90","author":"Otoni","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"B71","first-page":"59","article-title":"DNA immunization with the gene encoding Sm21. 7 protein protects mice against Schistosoma mansoni infections","volume":"2","author":"Ahmed","year":"2006","journal-title":"J Am Sci"},{"issue":"21","key":"B72","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1016\/j.vaccine.2009.02.096","article-title":"Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model","volume":"27","author":"Ahmad","year":"2009","journal-title":"Vaccine"},{"issue":"1\u00e2\u20ac\u201c3","key":"B73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000053656","article-title":"Vaccine strategies against schistosomiasis: from concepts to clinical trials","volume":"124","author":"Capron","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"B74","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-3024.1991.tb00545.x","article-title":"Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni","volume":"13","author":"Boulanger","year":"1991","journal-title":"Parasite Immunol"},{"issue":"12","key":"B75","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.vaccine.2004.09.018","article-title":"Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon","volume":"23","author":"Siddiqui","year":"2005","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T21:45:45Z","timestamp":1691703945000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2015.00273\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":75,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2015.00273","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725567103.793510444","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}